YLYibing Lv

Yibing Lv

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yibing Lv has a total of 45 co-authors. Here are the top co-authors by number of shared publications:

  • Chenyang Wang

    Institute of Medical Genetics, Henan Provincial People’s Hospital, Zhengzhou University People’s Hospital, Henan University People’s Hospital, Zhengzhou, China

    2 shared publications
  • Ji Hao

    School of Pharmaceutical Sciences, South-Central University for Nationalities, Wuhan 430074, China

    2 shared publications
  • Xinzhou Yang

    South-Central Minzu University

    2 shared publications
  • Zhenglong Guo

    Henan Provincial Key Laboratory of Genetic Diseases and Functional Genomics, Medical Genetics Institute of Henan Province, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, Zhengzhou, China

    2 shared publications
  • Biling Jiang

    Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

    1 shared publication
  • Chang Liu

    College of Life Sciences, South-Central University for Nationalities, Wuhan 430074, China

    1 shared publication

Latest Publications

  • Open Access

    Identification of a novel IGBP1 L49F variant in X‑linked intellectual disability

    by Jianmei Huang, Zhenglong Guo, Wenke Yang, Weili Shi, Zhaokun Wang, Xiaoliang Xia, Chenyang Wang, Jinming Wang, Yibing Lv, Shixiu Liao

  • Open Access

    Anti‐Diabetic Effects of Ayanin, a Flavonoid Compound, in STZ / HFD ‐Induced Diabetic Mice by Upregulating GLUT4 and Suppressing Macrophage‐Driven Inflammation in Adipose Tissues

    by Yibing Lv, Chunyu Wu, Wenke Yang, Chenyang Wang, Jianmei Huang, Jinming Wang, XiaoLiang Xia, Dong Wu, Ke Yang, Zhenglong Guo, et al.

    Insulin resistance, marked by reduced GLUT4 expression in metabolic tissues such as adipose tissue and skeletal muscle, is a key contributor to the pathogenesis of Type 2 diabetes. Therapeutic agents that enhance GLUT4 expression in these tissues have demonstrated potential in the treatment of diabetes. Ayanin (AYN) is a flavonoid found in red wine grapes. This study evaluated the anti‐diabetic properties of AYN and investigated its mechanisms. In an in vivo study, the oral administration of AYN to diabetic mice resulted in ameliorated hyperglycemia and glucose tolerance and alleviated lipid dysfunction. The investigation into the underlying mechanisms revealed that AYN activated p‐AMPKα, which subsequently enhanced GLUT4 and CPT‐1α expression in both adipose and muscle tissues, as well as increased CPT‐1α expression in livers. In vitro experiments demonstrated that AYN activated AMPKα, increased GLUT4 expression, and facilitated glucose uptake in 3T3‐L1 adipocytes. Additionally, the metabolic dysfunctions related to lipids and glucose in adipocytes triggered inflammatory activation of macrophages within adipose tissue, leading to the exacerbation of insulin resistance and the downregulation of GLUT4 expression. AYN reduced macrophage infiltration and pro‐inflammatory mRNA expression in adipose tissues, contributing to the amelioration of diabetes. In vitro results for macrophages indicated that AYN decreased LPS‐induced pro‐inflammatory cytokine secretion. These findings suggest that AYN has potential for improving glucose tolerance and hyperglycemia, reducing insulin secretion, alleviating macrophage inflammation, and mitigating lipid dysfunction.


  • GRP78 Downregulation in Keratinocytes Promotes Skin Inflammation through the Recruitment and Activation of CCR6+ IL-17A–Producing γδ T Cells

    by Liang Zhao, Jun Li, Biling Jiang, Jing Yang, Jiajia Lan, Danqi Li, Jingjing Wen, Yuting Xia, Wenjia Nie, Zhen Wang, et al.


  • Open Access

    A Novel Flavonoid Kushenol Z from Sophora flavescens Mediates mTOR Pathway by Inhibiting Phosphodiesterase and Akt Activity to Induce Apoptosis in Non-Small-Cell Lung Cancer Cells

    by Hao Chen, Jie Yang, Ji Hao, Yibing Lv, Lu Chen, Qinxiong Lin, Jingquan Yuan, Xinzhou Yang

    The roots of Sophora flavescens (SF) are clinically used as a traditional Chinese medicine for the treatment of various lung diseases. In this study, we investigated the mechanism by which SF inhibits proliferation and induces apoptosis in non-small-cell lung cancer (NSCLC) cells. A new compound, kushenol Z (KZ), and 14 known flavonoids were isolated from SF. KZ, sophoraflavanone G, and kushenol A demonstrated potent cytotoxicity against NSCLC cells in a dose- and time-dependent manner; KZ showed a wide therapeutic window. We also found that KZ induced NSCLC cell apoptosis by increasing the Bax/Bcl-2 ratio and by activating caspase-3 and caspase-9 leading to mitochondrial apoptosis, and upregulated CHOP and activatedcaspase-7 and caspase-12, which triggered the endoplasmic reticulum stress pathway. After KZ treatment, we observed cAMP accumulation, which reflected the inhibition of cAMP-phosphodiesterase (PDE), along with the increase in PKA activity; additionally, phospho-p70 S6 kinase was downregulated. KZ also attenuated the phosphorylation of Akt and PRAS40, which was partially rescued by an Akt activator. This suggested that KZ mediated the antiproliferative activity in NSCLC cells by inhibiting the mTOR pathway through the inhibition of cAMP-PDE and Akt. These findings suggested that KZ may be used as a promising cAMP-PDE and Akt inhibitor in targeted chemotherapeutic drug development.


  • Open Access

    Aspernolide A Inhibits the Proliferation of Human Laryngeal Carcinoma Cells through the Mitochondrial Apoptotic and STAT3 Signaling Pathways

    by Chang Liu, Hong Liu, Yanzhang Wen, Huiqi Huang, Ji Hao, Yibing Lv, Rui Qin, Xinzhou Yang

    Aspernolide A, a butyrolactone secondary metabolite, was purified from the endophytic fungus Cladosporium cladosporioides derived from roots of Camptotheca acuminata Decne. In this study, the antitumor activity and mechanisms of aspernolide A on human laryngeal cancer Hep-2 and TU212 cells were studied by MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay, morphological observation and Western blotting. The results showed that aspernolide A significantly inhibited the proliferation of Hep-2 and TU212 cells in dose- and time-dependent manners. Morphological changes of apoptotic cells could be observed under an inverted microscope, such as irregular margins, decreased adherence ability and chromatin condensation. The expressions of Bax, Caspase-9, Caspase-3 and PARP (poly ADP-ribose polymerase) increased with the increase of dosage while Bcl-2 decreased, suggesting that the apoptotic mechanism might be related to the mitochondrial apoptotic pathway. Moreover, the expression of the phosphorylation of STAT3 decreased with the increase of dosage, suggesting that the apoptotic mechanism might be related to the STAT3 signaling pathway. All these conclusions indicated that aspernolide A has the potential anti-laryngocarcinoma effects.


  • Open Access

    Particle Swarm Optimization Based on Smoothing Approach for Solving a Class of Bi-Level Multiobjective Programming Problem

    by Qingping He, Yibing Lv

    As a metaheuristic, Particle Swarm Optimization (PSO) has been used to solve the Bi-level Multiobjective Programming Problem (BMPP). However, in the existing solving approach based on PSO for the BMPP, the upper level and the lower level problem are solved interactively by PSO. In this paper, we present a different solving approach based on PSO for the BMPP. Firstly, we replace the lower level problem of the BMPP with Kuhn-Tucker optimality conditions and adopt the perturbed Fischer-Burmeister function to smooth the complementary conditions. After that, we adopt PSO approach to solve the smoothed multiobjective programming problem. Numerical results show that our solving approach can obtain the Pareto optimal front of the BMPP efficiently.